Dr. reddy's proposed rituximab biosimilar application accepted for review by usfda, ema and mhra

Hyderabad, india--(business wire)---- $rdy #biologicslicenseapplication--dr. reddy's proposed rituximab biosimilar application accepted for review by usfda, ema and mhra.

RDY Ratings Summary

RDY Quant Ranking